These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [The role of dialysis in the treatment of terminal renal insufficiency in children]. Picon G; Falque V; Caniot E; Dispa C; Bourlier-Najean B; Legre R; Viard L; Guys JM Ann Pediatr (Paris); 1991 Mar; 38(3):157-64. PubMed ID: 2039183 [TBL] [Abstract][Full Text] [Related]
64. Pediatric dialysis and renal transplantation in Kuwait over the past 11 years. El-Reshaid K; Kapoor MM; Nampoory MR; El-Reshaid W; Johny KV Pediatr Nephrol; 1999 Apr; 13(3):259-64. PubMed ID: 10353418 [TBL] [Abstract][Full Text] [Related]
65. Actuarial analysis of patient survival and dropout with various end-stage renal disease therapies. Prowant B; Nolph KD; Dutton S; Van Stone J; Whittier FC; Ross G; Moore H Am J Kidney Dis; 1983 Jul; 3(1):27-31. PubMed ID: 6346864 [No Abstract] [Full Text] [Related]
66. [The incidence of ESRD in 2011]. Briançon S; Lange C; Thibon P; Jacquelinet C; Stengel B Nephrol Ther; 2013 Sep; 9 Suppl 1():S19-37. PubMed ID: 24119582 [TBL] [Abstract][Full Text] [Related]
67. [Peritoneal dialysis - an alternative to hemodialysis in the center]. Vychytil A; Hörl WH Wien Med Wochenschr; 2013 Jun; 163(11-12):253-4. PubMed ID: 24000394 [No Abstract] [Full Text] [Related]
68. [How to promote kidney transplantation in Japan: perspective from a nephrologist]. Morozumi K; Takeda A Nihon Jinzo Gakkai Shi; 2004 Feb; 46(2):52-8. PubMed ID: 15058104 [No Abstract] [Full Text] [Related]
69. Optimal peritoneal dialysis for patients from Hong Kong. Lai KN; Lo WK Perit Dial Int; 1999; 19 Suppl 3():S26-31; discussion S32-4. PubMed ID: 10433549 [TBL] [Abstract][Full Text] [Related]
70. Treatment of children in the U.S. with end-stage renal disease (ESRD). Lewy JE Med Arh; 2001; 55(4):201-2. PubMed ID: 11769443 [TBL] [Abstract][Full Text] [Related]
71. Peritoneal dialysis and renal transplantation. Lobbedez T; Lecouf A; Abbadie O; Ficheux M; de Ligny BH; Ryckelynck JP Contrib Nephrol; 2009; 163():250-256. PubMed ID: 19494621 [TBL] [Abstract][Full Text] [Related]
73. Dialysis modality selection among patients attending freestanding dialysis facilities. Kendix M Health Care Financ Rev; 1997; 18(4):3-21. PubMed ID: 10175611 [TBL] [Abstract][Full Text] [Related]
74. Switching and the definition of modality in end-stage renal disease treatment. Smith DG; Wheeler JR Med Care; 1987 Dec; 25(12):1168-78. PubMed ID: 3320593 [TBL] [Abstract][Full Text] [Related]
75. Renal replacement therapy in yemen. Sheiban AK; Yehia A; Mohamed YA; Hajar AR Saudi J Kidney Dis Transpl; 1996; 7(3):313-4. PubMed ID: 18417950 [TBL] [Abstract][Full Text] [Related]
76. Specific and nonspecific immunoregulatory factors and renal transplantation. Donnelly P; Henderson R; Fletcher K; Stratton A; Lennard T; Wilson R; Proud G; Taylor R Transplantation; 1987 Oct; 44(4):523-8. PubMed ID: 3313839 [TBL] [Abstract][Full Text] [Related]
77. End-stage renal disease treatment modality and patients' quality of life. Longitudinal assessment. Kutner NG; Brogan D; Kutner MH Am J Nephrol; 1986; 6(5):396-402. PubMed ID: 3548354 [TBL] [Abstract][Full Text] [Related]